Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$3.25B |
| 2 |
Broadcom
AVGO
|
+$1.15B |
| 3 |
Netflix
NFLX
|
+$1.1B |
| 4 |
Truist Financial
TFC
|
+$1.07B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07B |
Top Sells
| 1 |
Intel
INTC
|
+$1.46B |
| 2 |
UnitedHealth
UNH
|
+$1.38B |
| 3 |
Coca-Cola
KO
|
+$1.24B |
| 4 |
Merck
MRK
|
+$905M |
| 5 |
Fiserv
FI
|
+$904M |
Sector Composition
| 1 | Technology | 20.93% |
| 2 | Healthcare | 18.46% |
| 3 | Communication Services | 14.42% |
| 4 | Financials | 11.83% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
MSCI
MSCI
$43.9B
| $268M | 0.11% |
929,104
+201,185
| +28% | +$58.1M |
|
152
Pfizer
PFE
$136B
| $268M | 0.11% |
8,669,139
-14,527,538
| -63% | -$450M |
|
|
SRE.PRA
153
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $268M | 0.11% |
2,898,911
+327,431
| +13% | +$30.3M |
|
|
NBL
154
DELISTED
Noble Energy, Inc.
NBL
| $268M | 0.11% |
44,291,435
-11,312,317
| -20% | -$68.3M |
|
|
AVGOP
155
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $261M | 0.11% |
278,911
+195,956
| +236% | +$183M |
|
156
Cisco
CSCO
$264B
| $260M | 0.11% |
6,604,661
+4,400,427
| +200% | +$173M |
|
157
Everest Group
EG
$13.8B
| $248M | 0.1% |
1,291,301
+432,049
| +50% | +$83.1M |
|
158
Cable One
CABO
$940M
| $241M | 0.1% |
146,681
-6,982
| -5% | -$11.5M |
|
159
Trip.com Group
TCOM
$49.9B
| $241M | 0.1% |
10,281,774
-1,623,367
| -14% | -$38.1M |
|
160
ICICI Bank
IBN
$115B
| $238M | 0.1% |
28,040,070
+6,705,384
| +31% | +$57M |
|
161
Gerdau
GGB
$6.23B
| $235M | 0.1% |
154,946,069
+23,059,504
| +17% | +$35M |
|
162
Air Lease Corp
AL
$7.1B
| $233M | 0.1% |
10,511,005
+2,776,493
| +36% | +$61.5M |
|
163
Nutrien
NTR
$27.5B
| $232M | 0.1% |
6,805,710
-1,540,132
| -18% | -$52.5M |
|
164
PepsiCo
PEP
$193B
| $228M | 0.09% |
+1,894,322
| New | +$228M |
|
165
KKR & Co
KKR
$128B
| $227M | 0.09% |
+9,679,758
| New | +$227M |
|
166
ON Semiconductor
ON
$19.9B
| $224M | 0.09% |
17,986,884
+8,965,654
| +99% | +$112M |
|
167
Alibaba
BABA
$383B
| $218M | 0.09% |
1,121,323
+492,897
| +78% | +$95.9M |
|
168
HubSpot
HUBS
$26.6B
| $207M | 0.08% |
1,556,463
+47
| +0% | +$6.26K |
|
169
East-West Bancorp
EWBC
$14.7B
| $207M | 0.08% |
+8,033,822
| New | +$207M |
|
170
Nasdaq
NDAQ
$53.2B
| $206M | 0.08% |
6,516,339
-1,901,844
| -23% | -$60.2M |
|
|
BHVN
171
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $204M | 0.08% |
6,003,735
+3,082,031
| +105% | +$105M |
|
172
Ares Management
ARES
$39B
| $204M | 0.08% |
6,586,942
| – | – |
|
|
NBIS
173
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.4B
| $203M | 0.08% |
5,964,174
+3,265,177
| +121% | +$111M |
|
174
Royal Caribbean
RCL
$86.6B
| $200M | 0.08% |
6,217,868
-2,347,952
| -27% | -$75.5M |
|
175
Amphenol
APH
$146B
| $198M | 0.08% |
+10,845,552
| New | +$198M |
|